Nestle signs an agreement for Alzheimer's disease diagnostic test

Published On 2015-09-24 06:34 GMT   |   Update On 2015-09-24 06:34 GMT
Advertisement
Making a serious commitment to the medical side of the business, Nestle is reported to have signed a research collaboration agreement with a Swiss biotech company to develop an Alzheimer's disease diagnostic test.

This new move by Food group Nestle shows its focus shifting to the lucrative medicine business from the food processing industry which is reported to have reached a stagnant point in many markets. The company definitely has the bandwidth and the clout in the market to foray into this new line of business, as commented in an
Advertisement
international newspaper
.

Nestle has now signed a Biotech firm AC Immune, which already has established ties with Roche in drug research, said on Wednesday it would develop a minimally invasive diagnostic assay for Tau with the Nestle Institute of Health Sciences.

Earlier last week the company had signed a separate deal to develop a new treatment for ulcerative colitis.

Tau is a protein that causes tangles in the brain that are a hallmark of Alzheimer's.

The financial terms of the deal were not disclosed.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News